Egenesis

EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It offers gene editing and genome engineering platform to develop human-compatible organs, tissues, and cells, aiming to provide an alternative solution to the global organ shortage.

1 past transactions

ICBiotec

Acquisition in 2020
ICBiotec aims to advance reproduction for mammalian species by providing cloning and associated services for domestic and international clients across academia and industry. ICB has grown with the advancement of molecular and reproductive biology and maintains state-of-the-art facilities and a highly skilled team of scientists and production personnel, with a focus on innovative reproductive technologies in livestock species.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.